Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Kidney International

• Publication date

  1998-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.1998.00139.XPMID 9844142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.

  1997cited by this paper
• Effect of Polymorphism of Apolipoprotein E and Angiotensin-Converting Enzyme Genes on Arterial Wall Thickness

  1997cited by this paper
• Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

  1997cited by this paper
• Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.

  1997cited by this paper
• Polymorphisms of the renin-angiotensin system genes in progressive renal diseases.

  1996cited by this paper
• Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta.

  1996cited by this paper
• Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.

  1996influential reference
• Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group.

  1995cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Environmental and Genetic Factors in Relation to Elevated Circulating Levels of Plasminogen Activator Inhibitor-1 in Caucasian Patients with Non-Insulin-Dependent Diabetes Mellitus

  1995cited by this paper
• Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

  1995cited by this paper
• Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.

  1995cited by this paper
• The treatment of the uraemic diabetic. Are we doing enough? A view from Japan. Fumitake Gejyo and Collaborate Study Group.

  1995cited by this paper
• A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease.

  1995cited by this paper
• ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.

  1995cited by this paper
• The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

  1995cited by this paper
• Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients

  1995cited by this paper
• Relationships Between Angiotensin I Converting Enzyme Gene Polymorphism, Plasma Levels, and Diabetic Retinal and Renal Complications

  1994cited by this paper
• Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors.

  1994cited by this paper
• Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of the Angiotensin I–Converting Enzyme Gene

  1994cited by this paper
• Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications.

  1994cited by this paper
• Pathogenesis of macrovascular disease in diabetes.

  1994cited by this paper
• Effect of angiotensin II on the expression of plasminogen activator inhibitor -1 in rat mesangial cells

  1994cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

  1993cited by this paper
• The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

  1993cited by this paper
• Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

  1992influential reference
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

  1992cited by this paper
• PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1).

  1992cited by this paper
• The plasminogen activator/plasmin system.

  1991influential reference
• Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus

  1990cited by this paper
• Book ReviewMild Head Injury

  1990cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats.

  1990cited by this paper
• Hypertension in diabetes mellitus.

  1988cited by this paper
• Epidemiology of Persistent Proteinuria in Type II Diabetes Mellitus: Population-Based Study in Rochester, Minnesota

  1988cited by this paper
• Diabetic control and microvascular complications: The near-normoglycaemic experience

  1986cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• Incidence and Prevalence of Clinical Peripheral Vascular Disease in a Population-based Cohort of Diabetic Patients

  1980cited by this paper
• Hypertension and diabetes mellitus.

  1958cited by this paper

• The Association of Genetic Polymorphisms Of Plasminogen Activator Inhibitor-1 4G/5G And Tissue Plasminogen Activator With Type 2 Diabetes Mellitus Is Influenced By Ethnicity

  2022cites this paper
• Novel Treatments and the Future of DKD: What Is on the Horizon?

  2022cites this paper
• Serpin Family E Member 1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetic Nephropathy: An Association Study and Meta-Analysis Using a Genetic Model-Free Approach

  2021cites this paper
• The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications: a meta-analysis of fifty-one case-control studies

  2021cites this paper
• Association of plasminogen activator inhibitor-1 4G5G Polymorphism with risk of diabetic nephropathy and retinopathy: a systematic review and meta-analysis

  2020cites this paper
• Risk of recurrent pregnancy loss in the Ukrainian population using a combined effect of genetic variants

  2019cites this paper
• Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Type 2 Diabetic Nephropathy in Asian Populations: An Updated Meta-analysis.

  2019cites this paper
• Electronic Supplementary Material

  2019cites this paper
• −675 4G/5G and −844 G/A of Plasminogne Activator Inhibitor-1 (Pai-1) Gene Polymorphisms and Type 2 Diabetes Mellitus in Tunisia: Case-Control Study

  2019cites this paper
• Association of SERPINE1 rs6092 with type 2 diabetes and related metabolic traits in a Chinese population.

  2018cites this paper
• Influence of Plasminogen Activator Inhibitor -1 Gene Polymorphism on Renal Scarring After First Febrile Urinary Tract Infection in Infants

  2018cites this paper
• Plasminogen Activator Inhibitor Type-1 Tag Single-Nucleotide Polymorphisms in Patients with Diabetes Mellitus Type 2 and Diabetic Retinopathy

  2017cites this paper
• Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy

  2016cites this paper
• Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy—A Meta-Analysis Comprising 10,168 Subjects

  2016cites this paper
• Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population

  2016cites this paper
• Role of ACE and PAI-1 Polymorphisms in the Development and Progression of Diabetic Retinopathy

  2015cites this paper
• 4 G/4 G polymorphism of plasminogen activator inhibitor-1 gene increases the risk of diabetic nephropathy

  2014cites this paper
• Novel Treatments and the Future of Diabetic Nephropathy: What Is on the Horizon?

  2014cites this paper
• Human Genetics of Diabetic Cardiovascular Complications

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk.

  2013cites this paper
• PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study

  2013influential citation
• Human genetics of diabetic vascular complications

  2013cites this paper
• Impact of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene on childhood IgA nephropathy.

  2012cites this paper
• Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects

  2012cites this paper
• Patient's knowledge of diabetes, its ocular complications and management in a private practice population in the Western Cape, South Africa.

  2011cites this paper
• The Effect Of Glycemic Control And Renin Angiotensin System Inhibition On Proliferative Diabetic Retinopathy In Streptozotocine Induced Diabetes: A Controlled Study Of Insulin And Ace Inhibitor

  2010cites this paper
• Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes

  2010cites this paper
• PAI-1 and kidney fibrosis.

  2009cites this paper
• Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction

  2009cites this paper
• Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.

  2008cites this paper
• Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes

  2007cites this paper
• Candidate Genes for Late Diabetic Complications

  2007cites this paper
• The clot thickens.

  2006cites this paper
• Combinational effect of genes for the renin–angiotensin system in conferring susceptibility to diabetic nephropathy

  2006cites this paper
• Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.

  2006cites this paper
• The Renin—Angiotensin System in Diabetic Cardiovascular Complications

  2005cites this paper
• Frequency of angiotensin‐converting enzyme gene polymorphism in Turkish type 2 diabetic patients

  2005cites this paper
• Angiotensinogen and Plasminogen Activator Inhibitor-1 Gene Polymorphism in Relation to Renovascular Disease

  2005cites this paper
• Preventing end stage renal disease in diabetic patients — genetic aspect (part I)

  2005cites this paper
• Examination of Hardy-Weinberg equilibrium in papers of Kidney International: an underused tool.

  2004cites this paper
• Close relationship of plasminogen activator inhibitor-1 4G/5G polymorphism and progression of IgA nephropathy.

  2004cites this paper
• Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms.

  2004cites this paper
• Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.

  2003influential citation
• Genetic factors related to progression of type 2 diabetic nephropathy in Japanese

  2003cites this paper
• A Plasminogen Activator Inhibitor-1 Promoter Polymorphism and Idiopathic Interstitial Pneumonia

  2003cites this paper
• Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages.

  2003cites this paper
• PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis.

  2003cites this paper
• Insertion/Deletion Plasminogen Activator Inhibitor 1 and Insertion/Deletion Angiotensin-Converting Enzyme Gene Polymorphisms in Diabetic Retinopathy in Type 2 Diabetes

  2003cites this paper
• Inherited Thrombophilia: Impact on Human Reproduction

  2003cites this paper
• Chronic graft dysfunction in renal transplant patients1: potential role of plasminogen activator inhibitor type 1

  2002cites this paper
• Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis.

  2002cites this paper
• Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy.

  2002cites this paper
• Angiotensinogen and plasminogen activator inhibitor‐1 gene polymorphism in relation to chronic allograft dysfunction *

  2002cites this paper
• CHRONIC GRAFT DYSFUNCTION IN RENAL TRANSPLANT PATIENTS

  2002cites this paper
• Coagulation, Fibrinolysis and Angiogenesis: New Insights from Knockout Mice

  2002cites this paper
• Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies.

  2002cites this paper
• Review: The genetics of macrovascular disease in diabetes

  2002cites this paper
• Angiotensin as inducer of plasminogen activator inhibitor-1 and fibrosis.

  2001cites this paper
• Progression and potential regression of glomerulosclerosis.

  2001cites this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cites this paper
• Role of angiotensin II in glomerular injury.

  2001cites this paper
• Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.

  2001cites this paper
• Genetic background: patients.

  2001cites this paper
• Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.

  2001cites this paper
• Delayed branching of endothelial capillary-like cords in glycated collagen I is mediated by early induction of PAI-1.

  2001cites this paper
• The plasminogen activator inhibitor 1 4G/5G polymorphism is not associated with longevity: a study in octogenarians

  2001influential citation
• Diabetes and Nephropathy

  2001cites this paper
• Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

  2000cites this paper
• Pathology of progressive nephropathies.

  2000cites this paper
• ACE gene polymorphism and survival in atherosclerotic renovascular disease.

  2000cites this paper
• Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.

  2000cites this paper
• Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.

  2000cites this paper
• The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis.

  2000cites this paper
• New insights into the renin-angiotensin system and hypertensive renal disease

  1999cites this paper
• Detection of point mutations on a DNA microchip

  1999cites this paper
• Mesangial Matrix Modulation and Glomerulosclerosis

  1999cites this paper
• Compound interest: ACE and PAI-1 polymorphisms and risk of thrombosis and fibrosis.

  1998cites this paper